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Abstract
All the well-defined DNA-packaging motors of the dsDNA viruses contain one pair of nonstructural DNA-packaging enzymes. Studies
on the mechanism of virus DNA packaging have been seriously hampered by their insolubility. Phi29’s DNA-packaging enzyme, gp16, is
also hydrophobic, insoluble, and self-aggregating. This article describes approaches to obtain affinity-purified, soluble, and highly active
native gp16 with the aid of polyethylene glycol or acetone. The specific activity of this native gp16 was increased 3400-fold when compared
with the traditional method. This unique approach made the ATP–gp16 interaction study feasible. Gp16 binds strongly to ATP, binds to
ADP with a lower efficiency, and binds very weakly to AMP. The order of gp16-binding efficiency to the four ribonucleotides is, from high
to low, ATP, GTP, CTP, and UTP. The ATP concentration level required to produce 50% of maximum virus yield exhibited during in vitro
phi29 assembly is around 45 M, which is close to the gp16 and ATP dissociation constant of 65 M. Mutation studies revealed that
changing only one conserved amino acid, whether R17, G24, G27, G29, K30, or I39, in the predicted Walker-A ATP motif of gp16 caused
ATP hydrolysis and viral assembly to cease, while such mutation did not affect gp16’s binding to ATP. However, mutation on amino acids
G248 and D256 did not affect the function of gp16 in DNA packaging.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
One striking feature in the assembly of linear dsDNA
viruses, including bacteriophages, adenoviruses, poxvi-
ruses, and herpesviruses, is that the viral genome is pack-
aged into a performed procapsid during maturation (Bazinet
and King, 1985; Casjens and Hendrix, 1988; Black, 1995;
Lee and Guo, 1994). DNA packaging as an essential viral
replication step has been investigated in the quest for new
antiviral drugs. Factors involved in DNA packaging have
been used as model targets for inhibiting viral replication
(Trottier et al., 1996; Zhang et al., 1995) and for the devel-
opment of drugs against CMV (Bogner, 2002). All DNA-
packaging motors involve nonstructural components. These
components have been classified into two categories accord-
ing to their role in DNA packaging: procapsid binding (the
larger subunit) and interaction with DNA (the smaller sub-
unit) (Guo et al., 1987b). Procapsid binding components
include gpA in phage lambda (Catalano et al., 1995), gp12
in phi21 (Feiss et al., 1985), gp17 in T4 (Rao and Black,
1988), gp19 in T3 and T7 (Morita et al., 1993), and gp16 (?)
or pRNA in phi29 (Guo et al., 1987a; Garver and Guo,
1997; Shu and Guo, 2002; Guo, 2002). Components inter-
acting with DNA include gpNu1 in lambda, gp1 in phi21,
gp16 in T4, gp3 in phi29, and gp18 in T3/T7. Emerging
information reveals that the mechanism of herpesvirus DNA
packaging is very similar to that of phages (Newcomb et al.,
2001; Hwang and Bogner, 2002). Studies on the mechanism
of DNA packaging and the design of drugs targeting the
DNA-packaging protein have been seriously hampered by
the insolubility of this kind of protein after expression and
their self-aggregation after purification. Since most of these
proteins have been cloned, overexpressed, and purified,
some interesting data on the ATPase activity assay of the
DNA-packaging proteins have been reported (Hwang et al.,
1996; Tomka and Catalano, 1993; Grimes and Anderson,
1990; Guo et al., 1987b; Hamada et al., 1987; Mitchell et
al., 2002). However, progress in the stoichiometric quanti-
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fication and mechanistic investigation of these proteins has
been far from satisfactory. Not a single crystal structure of
these proteins has been reported.
The hydrophobicity, insolubility, and self-aggregation of
phi29 gp16 have hindered further refinement of our under-
standing of the mechanism of this DNA-packaging motor.
Contradictory data regarding ATPase activity, binding lo-
cation, and the stoichiometry of gp16 have been published
(Guo et al., 1987b; Grimes and Anderson, 1990; Ibarra et
al., 2001). All discrepancies have arisen due to the lack of
a method to make gp16 completely soluble. Little progress
has been made since the gene coding for gp16 was cloned
into Escherichia coli and overproduced 15 years ago (Guo
et al., 1986). In that traditional method, gp16 was purified in
denatured condition and active gp16 was obtained by dial-
ysis against 4 mM KCl buffer for 40 min that allowed for
renaturation. Nevertheless, the gp16 aggregated again
within 20 min after renaturation. Recently, it was reported
that gp16 was made soluble in the cell by coexpression with
groE (Ibarra et al., 2001). Indeed, active gp16 has been
purified from this overexpression system. However while
the coexpression with groE solved the problem of aggrega-
tion in the cell, it could not solve the problem of self-
aggregation after purification. There is a great need for a
procedure to make pure, soluble, active, and stable gp16,
which would allow for further characterization of such a
fascinating molecular motor.
This article describes approaches utilized to obtain ho-
mogeneous, soluble, active, and stable gp16 by the use of a
Ni-agarose column, polyethylene glycol (PEG), or acetone.
This gp16 construction and preparation enables us to pro-
vide the first direct evidence that gp16 specifically binds to
ATP. The interactions of gp16 with ATP, ADP, and AMP as
well as GTP, CTP, and UTP were also characterized. Nine
site-directed mutant gp16s with mutation at the predicted
Walker-A motif were also constructed and purified. With
the ATPase assay, the results confirmed that the Walker-A
motif involves G27I28G29K30S31.
Results
PEG and acetone greatly enhance the solubility and
activity of gp16
The His-tagged gp16 purified by a Ni-agarose column
was completely inactive in phi29 DNA packaging after
column elution. The loss of activity was due to self-aggre-
gation of the His-tagged gp16 after purification, since the
formation of white precipitates was observed.
The effect of individual organic solvents on gp16 activity
was tested. PEG (Huang and Guo, 2003) and acetone were
the chemicals most efficient in the restoration of gp16 ac-
tivity. The affinity-purified gp16 was dissolved in PEG
buffer (15% PEG 8000, 5% glycerin, 100 mM NaCl, 20 mM
Tris–HCl, pH 7.8) and was active following storage at less
than 20°C for at least 1 year. Five percent of acetone
could replace 15% PEG, but gelatin and Tween 20 could
not. This PEG buffer not only could be used for native
His-tagged gp16, but also could be used to renature the gp16
that had been denatured by guanidine chloride (GuCl) and
to enhance its activity as well. With PEG, the specific
activity of native gp16 increased 3400-fold in comparison to
the traditional GuCl–KCl method (Huang and Guo, 2003).
Binding of gp16 to ATP
An ATP-affinity agarose column was used to detect
whether the native, soluble, and pure His-tagged gp16 could
bind ATP. Purified His-tagged gp16 in binding buffer was
applied to an ATP affinity column. The majority of the
His-tagged gp16 was found to bind to the ATP matrix (Figs.
1-3,5). The bound His-tagged gp16 was eluted by a binding
buffer containing ATP. When procapsid, or gp12 (Fig. 1),
was applied to the column, it was found that neither of these
components bound to the ATP column and that the majority
appeared in the first several fractions (the void volume);
neither of the proteins were eluted with the addition of ATP.
These results provide strong evidence that His-tagged gp16
specifically binds to ATP. Similarly, wild-type gp16 with-
out the fusing tag and prepared by the traditional method
(Guo et al., 1986) also specifically bound to the ATP col-
umn and was eluted by ATP (data not shown). This suggests
that such binding to ATP is an intrinsic feature of gp16, one
that is independent of the fusing tag.
Comparison of gp16-binding efficiency to ATP, ADP, and
AMP
ATP, ADP, and AMP-affinity agarose resins, attached at
the C-8 position to cyanogen bromide-activated agarose,
were tested to compare their binding efficiencies to His-
Fig. 1. ATP-binding assay for His-tagged gp16 with ATP-agarose affinity
column. His-tagged gp16, procapsid, and gp12 in binding buffer were
applied onto an ATP-agarose affinity column and washed with binding
buffer. The pass-throughs were collected as fractions. The mark “ATP-
added” indicates that elution buffer containing 10 mM ATP was added to
the column when fraction 6 or 7 was collected. These fractions were further
applied to 10% SDS–PAGE and protein bands were detected by silver
stain. The unbound protein appeared in the first several fractions (the void
volume). His-tagged gp16 was eluted out with the addition of ATP, while
procapsid and gp12 were not.
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tagged gp16 (Figs. 2A, D, and E). When binding buffer
containing ATP was applied to the column, a large amount
of His-tagged gp16 was eluted, as detected by in vitro
assembly assay. The elution profile obtained with the in
vitro phi29 assembly assay agreed with the data from the
dot-blot protein assay, SDS–gel electrophoresis, and silver
stain detection. Very little His-tagged gp16 was eluted from
AMP-affinity column when it was eluted with binding
buffer containing AMP. The ratio of the eluted peak and the
peak in void volume was about 104 for ATP, 0.7 for ADP,
and 0.2 for AMP (Fig. 2) (Table 1).
Binding efficiency of gp16 to ATP with different linkage
positions to agarose resin
ATP resins with different attachment positions were used
to compare relative differences in His-tagged gp16-binding
efficiency. It was found that the ATP resin with an attach-
ment position of C-8 had the highest binding efficiency,
while those with an attachment position of N-6 or ribose
hydroxyl exhibited a much lower binding efficiency (Figs.
2A, B, and C). Similarly, His-tagged gp16 could not bind to
ADP resin with the attachment position of ribose hydroxyl
(data not shown).
Comparison of gp16-binding efficiency for ATP, CTP,
GTP, and UTP
To compare the binding efficiency for ATP, CTP, GTP,
and UTP, His-tagged gp16 was first attached to the ATP-
agarose gel. After washing with an excess amount of bind-
ing buffer, the bound His-tagged gp16 was then eluted by
the buffer containing 10 mM of ATP, CTP, GTP, and UTP,
respectively (Fig. 3). It was found that ATP buffer could
elute the bound His-tagged gp16 effectively, while the UTP
and CTP buffers were less efficient. The binding efficiency
of GTP fell between that of ATP and UTP. This indicates
that His-tagged gp16 has the highest affinity for ATP bind-
ing and the lowest affinity for UTP and CTP.
Determination of dissociation constant (Kd)
The Kd for free ATP and His-tagged gp16 was deter-
mined to be 65 M (Fig. 4A) using the double reciprocal
plotting method. This determination is done by a Microcon
spin column approach (see Materials and methods). The
concentration requirement of ATP for phi29 assembly was
determined through titration by the in vitro assembly system
(Fig. 4B). The minimum ATP concentration required to
produce a maximum yield of phi29 was about 100 M. The
ATP concentration required for half-activity was 45 M,
which is close to the dissociation constant of 65 M.
Mutation on the putative Walker-A motif
Nine site-directed mutant His-tagged gp16s (Table 2)
were constructed with mutation at conserved amino acids of
predicted Walker-A motif (residues 17–31). This ATP motif
has been predicted by sequence comparison (Guo et al.,
1987b). ATPase and DNA-packaging assays showed that
changing any one of the conserved amino acids, K30 3 T,
R17 3 E, G24 3 D, G27 3 D, G29 3 S, K30 3 H, I39 3
K, and I39 3 E, in the putative Walker-A motif hindered
gp16 activities (Fig. 6 and Table 2). ATP-binding assay
showed that this loss of activity was not due to a loss of
binding of gp16 to ATP (Fig. 5 and Table 2).
A notable phenomenon in mutagenesis study of gp16s
was observed: All gp16s with a mutation at the putative
Walker-A motif exhibited lower soluble protein yields dur-
ing protein purification (Table 2). Wild-type gp16 is hydro-
phobic and tends to self-aggregate. Mutation deteriorates
the solubility of gp16; as a result, purification of all of these
mutant gp16s with mutations targeting at the putative
Walker-A motif proved to be difficult. This was especially
true when I39 was changed to K or E. Mutant gp16s with
G293 S & K303 I, G273 D, R173 E, or G243 D were
purified, taking advantage of the His-tag column’s simplic-
ity. These mutant gp16s were found to be able to both bind
ATP using S-tag Western blot assay (Fig. 5) and inhibit
phi29 assembly. We also tried to study mutations of other
gp16 residues. It was found that changing G248 to S, or D256
to H, did not affect the activity of gp16 (Table 2).
ATPase activity of gp16 and mutants
Thin-layer chromatography revealed that the mixture of
procapsid, pRNA, and DNA-gp3 (lanes 2, 10 of Fig. 6)
contained very little ATPase activity. With the addition of
His-tagged gp16 to this reaction mixture, ATPase activity
increased dramatically (lanes 8, 16 of Fig. 6). The purified
His-tagged gp16 alone also exhibited very low ATPase
activity (lanes 7, 15 of Fig. 6). This result confirmed our
previous finding (Guo et al., 1987b) that the ATPase activity
of gp16 is procapsid dependent. When mutant His-tagged
gp16s, G293 S & K303 I, G273 D, R173 E, or G243
D, were added to the mixture, little ATPase activity was
detected (lanes 4, 6, 12, and 14 of Fig. 6). This data indicate
that residues R17, G29, K30, G27, and G24 are critical for
ATPase activity and confirms that G27I28G29K30S31 is in the
Walker-A motif.
Discussion
Interactions between DNA and cationic polymers, in-
cluding polylysine and PEG, have attracted attention. PEG
has been found to enhance the efficiency of DNA packaging
(Serwer et al., 1983; Louie and Serwer, 1994). Cationic
polymers appear to have the efficiency to regulate the phys-
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Fig. 2. Comparison of His-tagged gp16-binding efficiency to ATP-agarose resins with different sites of linkage (A–C) and His-tagged gp16-binding efficiency
to ATP, ADP, and AMP (A, D, E).
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icochemical and biological properties of polycation/DNA
complexes. Polymers promote the formation of complexes
by facilitating the oriented self-assembly of DNA with cat-
ionic-hydrophilic copolymers, which could enshroud the
complex within a protective hydrophilic polymer corona.
Therefore, polymers could stimulate the packaging of nu-
cleic acid in vitro (Toncheva et al., 1998; Yoshikawa,
1997). The phenomenon of PEG enhancement has been
connected to the mechanism of viral DNA packaging (Ser-
wer et al., 1983; Louie and Serwer, 1994), and our results
indicate that PEG does indeed enhance the packaging effi-
ciency of phi29. However, it is clear from this study that this
enhancement is mainly due to the promotion of gp16 solu-
bility. Whether the aforementioned hydrophilic polymer
corona effect could facilitate the packaging of phi29 DNA
remains to be investigated.
Other organic solvents such as chloroform, n-octyl--D-
glucoside (OG), ethanol, and acetonitrile were found inef-
fective, likely due to the solvents’ attendant inactivation of
other protein components involved in the assembly of in-
fectious phi29 virus. This by no means indicates that other
organic solvents could not help to dissolve gp16 and restore
its activity.
Comparison of the DNA-packaging proteins, UL15 of
herpesvirus (Yu and Weller, 1998), IVA2 of adenovirus,
A32 of poxvirus (Amegadzie et al., 1991), gp16 of phi29
(Guo et al., 1987b), gp19 of T3 (Yamada et al., 1986), gp17
of T4 (Black, 1995), gp2 of P22 (Eppler et al., 1991), B
protein of P1 (Skorupski et al., 1992), terminase of psiM2
(Pfister et al., 1998), terminase of Sfi21 (Desiere et al.,
1998), gpA of lambda (Catalano et al., 1995), gp1Y of
phiC31 (Bentley, 2002), and gp19 of T7 (Serwer et al.,
1983), reveals that most of these proteins contain a con-
served Walker-A motif (G/A)XXXXGK(S/T) (Guo et al.,
1987b; Mitchell et al., 2002).
We also compared gp16’s binding with different agarose
Table 1
Comparison of gp16 binding efficiency for nucleotides
Nucleotides Peak activity in
void volume
(PFU/ml)
Peak activity in
elution volume
(PFU/ml)
Ratio of peak
activity
(gp16b/gp16ub)
Ranking of Gp16
binding affinity
ATP 1.1 104 1.2  108 1  104 1
ADP 1.4 107 1.0  107 0.7 2
AMP 1.2 107 2.4  106 0.2 3
Gp16b, bound gp16; Gp16ub, unbound gp16.
Fig. 3. Comparison of His-tagged gp16-binding efficiency to ATP, GTP,
CTP, and UTP. His-tagged gp16 was applied onto an ATP-agarose affinity
column and washed with binding buffer. His-tagged gp16 was eluted by 10
mM ATP, GTP, CTP, and UTP. The arrows indicate that the specific
nucleotide was added to the binding buffer.
Fig. 4. (A) Double-reciprocal plot to determine the dissociate constant (Kd)
of His-tagged gp16/ATP complex. The slope of this line, 65 M, stands for
the Kd of His-tagged gp16 and ATP. (B) ATP concentration requirement
for virion assembly with the standard phi29 in vitro assembly system.
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linkage sites of ATP to see which linkages block the pro-
tein/ATP interaction. If a site of ATP is important for gp16
binding, modifying this site by attaching agarose will defi-
nitely affect its binding efficiency with gp16. ATP-binding
assays showed that ATP resin with an attachment site of C-8
had the highest binding efficiency for gp16, while with an
attachment site of N-6 or ribose hydroxyl showed lower
binding efficiency (Fig. 2). This suggests that N-6 or ribose
hydroxyl is important for ATP/gp16 interaction, a specula-
tion that is further supported by the ADP-binding assay.
ADP columns with an attachment site of N-6 or ribose
hydroxyl exhibit almost no binding to gp16. Studies on the
crystal structure of other ATPases that have a conserved
Walker-A motif, such as MinD (Hayashi et al., 2001), have
revealed that N-6 and ribose hydroxyls are needed to secure
the ATP at binding pockets by forming hydrogen bonds
with backbone amino acids. N-6 forms hydrogen bonds
with the “O¢C—” group of Asn or Pro. Ribose hydroxyl
forms hydrogen bonds with the “OH—” group of Ser or
Thr, and with the “—NH2” group of Arg, His, or Lys. The
C-8 position did not show specific interaction with back-
bone amino acids. Since gp16 contains the conserved
Walker-A motif, it is not surprising to find that linkage
through N-6 and ribose hydroxyls blocks their interaction
with gp16. It is also likely that the poor binding affinities of
N-6 and ribose hydroxyl columns are due to a steric effect
Table 2
Summary of Mutant gp16s
Location of mutation Change of residues Assembling
activity
(PFU/ml)
Solubility ATP
binding
Procapsid/DNA
dependent ATPase
activity
Predicted Walker-A motif G29 3 S & K30 3 I 0   
K30 3 T 0  N/A N/A
R17 3 E 0   
G24 3 D 0   
G27 3 D 0   
G29 3 S 0   N/A
K30 3 H 0   N/A
I39 3 K 0  N/A N/A
I39 3 K 0  N/A N/A
Other mutations G248 3 S 108  N/A N/A
D256 3 H 108  N/A N/A
Wild-type gp16 108   
PFU, plaque forming unit; N/A, data not available; , not soluble or no ATPase activity.
Fig. 5. S-Tag Western blot assay for ATP binding efficiency of mutant
His-tagged gp16s. The series of dots represents the fractions as labeled at
the top. Data of fractions 10–13 were omitted from this figure.
Fig. 6. Thin-layer chromatogram showing hydrolysis of [-32P]ATP by
gp16 and related mutants. Lane 1; [-32P]ATP only; 2; proheads, RNA,
and DNA-gp3; 3; mutant G29S&K30I; 4; proheads, RNA, DNA-gp3, and
mutant G29S&K301; 5; mutant G27D. Lane 6: proheads, RNA, DNA-gp3,
and mutant G27D; 7; His-tagged gp16; 8; proheads, RNA, DNA-gp3, and
His-tagged gp16; 9; [-32P]ATP only; 10; proheads, RNA, and DNA-gp3;
11; mutant G29S; 12; proheads, RNA, DNA-gp3, and mutant G29S; 13;
mutant K30H; 14; the proheads, RNA, DNA-gp3, and mutant K30H; 15;
His-tagged gp16; 16; proheads, RNA, DNA-gp3, and His-tagged gp16.
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of altered orientation of nucleotide. This is another area for
potential investigation.
Gp16 had higher affinity for ATP than for ADP and
AMP. Since the ATP, ADP, or AMP resins used in these
assays all link to agarose at the same C-8 position, the
resulting steric effects are the same and thus their binding
affinities with gp16 are comparable (Figs. 2A, D, and E)
(Table 1). Our agarose gel binding assay revealed that gp16
had a high affinity for ATP, while having a lower affinity for
ADP and AMP. All of these findings help explain why gp16
and ATP are needed for the packaging of viral DNA. Ex-
hibiting a higher affinity for ATP, gp16 will trap ATP.
Having less affinity for ADP and AMP, gp16 will release
ADP or AMP after hydrolysis. The alternative binding and
releasing of ATP and its hydrolyzed substrate will in turn
result in a conformational change in gp16, which will pro-
duce the physical force. Site-directed mutagenesis results
indicate that the conserved amino acids at the predicted
Walker-A motif are important for the ATPase activity of
gp16. The conserved amino acids G24, G29, K30, and S31
may interact with  and  phosphate through hydrogen
bonding (HN..O¢P).
Mutant gp16s with change(s) at the consensus amino
acids of the Walker-A motif were inactive in phi29 DNA
packaging but were still able to bind ATP (Table 2 and Fig.
5). This is not surprising since binding to ATP requires
multiple residues to form an ATP-binding pocket, and the
other unchanged, conserved amino acids could still hold the
ATP. ATPase assays revealed that these mutants actually
lost ATPase activity, suggesting that the amino acids in the
Walker-A motif are involved not only in the binding for
ATP, but also in ATP hydrolysis. Recently it was predicted
that the Walker-B motif of gp16 is the sequence
T77I78V79F80D81 (Mitchell et al., 2002). The validity of this
prediction remains to be confirmed by the change of the
acidic D81/E82 to other basic amino acids, following the
approach used in this studies for Walker-A motif.
Materials and methods
ATP-binding assay using ATP-agarose affinity column
The gene for gp16 was fused with a 109 amino acid
thioredoxin, a six-His-tag, and a 15 amino acid S-tag
(Huang and Guo, 2003). Both His-tag and S-tag were placed
between thioredoxin and gp16. The S-tag served as a marker
for gp16 identification. The size of the resulted His-tagged
gp16 is 54 kDa. It was purified by one-step Ni-agarose
column to homogeneity (Huang and Guo, 2003).
A 0.8-cm-diameter column was packed with 1 ml ATP-
affinity agarose resin (Sigma) (5 mM ATP immobilized
through the C-8 position of the base to cyanogen bromide
activated agarose). The lyophilized resin was soaked in
distilled water for more than 30 min before column packing.
After washing with 12 ml of distilled water and then with 12
ml of binding buffer (100 mM NaCl, 2 mM MgCl2, 1 mM
DTT, 5% glycerol, 20 mM Tris–HCl, pH 7.8), 100 l of
His-tagged gp16 (30 g) in binding buffer was applied to
the ATP affinity column. The column was then washed with
7 ml of binding buffer and eluted with 3–5 ml of binding
buffer containing 10 mM ATP. Fractions (0.5–1 ml/frac-
tion) were collected and subjected to S-Tag dot blot assay
(see below), 10% SDS–polyacrylamide gel electrophoresis
(SDS–PAGE), silver stain detection, or activity assay for in
vitro phi29 assembly. Similar approaches were applied to
other resins.
Double-reciprocal plotting Kd determination
His-tagged gp16 was attached to the His-resin to form a
gp16/His-resin complex. Thirty microliters of the complex
was transferred into each Microcon YM-30 (Millipore),
equilibrated with ATP-binding buffer, and then spun at 4°C
to remove the liquid. Binding buffer (150 l) containing
different concentrations of ATP, which were mixed with
[-32P]ATP (Amersham), ranging from 0.8 M to 500 M,
were added to the gp16-enriched His-resin in Microcons.
After mixing and 5-min incubation, the mixture was spun
for 3 s at 14,000 rpm in a microcentrifuge to separate the
bound and unbound ATP. The pass-through liquid was
collected. Twenty microliters of each aliquot was applied to
a liquid scintillation counter. In the double-reciprocal plot-
ting method, the equation (r Kd/[ATP] 1) was used. 1/r
versus 1/[ATP] gives a straight line, and the slope of this
line represents the Kd. r is defined as the amount of ATP
bound to 1 mole of His-tagged gp16, and r  [ATP]bound/
[gp16]total.
Construction of site-directed mutant gp16s
A site-directed mutagenesis kit (QuickChange, Strat-
agene) was used to make point mutations. Both primers
containing the desired mutation were annealed to the meth-
ylated plasmid PART7ED that contained the gp16 gene and
polymerized by the high-fidelity DNA polymerase Pfu-
Turbo. DpnI digestion was performed to remove the meth-
ylated, nonmutated parental DNA template. The resultant
circular, nicked dsDNA plasmids were transformed into E.
coli XL1-Blue supercompetent cells. Mutations were con-
firmed by DNA sequencing. These mutants were then sub-
cloned into the pET-32 vector to produce His-tag fusion
gp16. Mutant His-tagged gp16s were then purified using
Ni-agarose column chromatography as described above.
Detection of His-tagged gp16 by S-tag Western blot
A dot-blotting apparatus (Millipore) was used to transfer
protein samples to an Immobilon-P transfer membrane. The
membranes were pretreated with blocking buffer (10 mM
Tris–HCl, pH 8.0, 150 mM NaCl, 0.1% Tween 20, and 1%
gelatin) for 15 min. The membranes were then incubated for
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another 15 min in TBST buffer (10 mM Tris–HCl, pH 8.0,
150 mM NaCl, 0.1% Tween 20) containing S-protein alka-
line phosphatase conjugate. After washing four times with
TBST buffer, the blots were incubated for 15–30 min in the
alkaline phosphatase buffer containing the substrates NBT/
BCIP for color development.
ATPase assay by thin-layer chromatography (TLC)
His-tagged gp16 or mutants (G29S&K30I, R17E, G24D,
and G27D) (0.2 mg/ml), DNA-gp3 (0.1 g), procapsid (10
g), and RNA (200 ng) were assayed individually and in
combination for ATPase activity. When one or more con-
stituents were omitted, they were replaced with the appro-
priate volume(s) of TMS buffer (100 mM NaCl, 10 mM
MgCl2, 50 mM Tris–HCl, pH 7.8). The reaction mixture
contained 0.1 mM of unlabeled ATP and 30 Ci/ml of
[-32P]ATP (Guo et al., 1987b). After 30 min of incubation
at room temperature, 2 l of the reaction mixture was
spotted onto a PEI-cellulose plate (J.T. Chemical Co.) and
air-dried. The plates were then soaked in methanol for 5
min, air-dried, and run in 1 M formic acid and 0.5 M lithium
chloride.
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